血清水平和住院心力衰竭患者的死亡率
Bo-Ping Huang1, Lang Zhao1, Xue-Mei Zhao1
1Heart Failure Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), 100037 Beijing, China.
血清水平显著影响住院心力衰竭患者的死亡风险. 低和非常高水平都与增加全因死亡率有关,这表明狭窄的治疗范围至关重要.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
- 临床研究 临床研究
背景情况:
- 心力衰竭是住院和死亡的主要原因之一.
- 电解质平衡,特别是血清 (K+),在心血管功能中起着至关重要的作用.
- 了解血清K+水平与HF患者的结果之间的关系对于优化治疗至关重要.
研究的目的:
- 调查血清水平与心力衰竭住院患者全因死亡率之间的关联.
- 为了确定特定的水平范围 (低血或高血) 是否与死亡风险增加有关.
- 为了确定住院HF患者潜在的最佳血清范围.
主要方法:
- 分析了3114名住院心力衰竭患者的队列.
- 根据出院前的血清四分位数,患者被分为四组.
- 所有原因的死亡率在90天,2年以及最大随访期间进行了评估.
主要成果:
- 在高四分位数 (Q4,K+ ≥4.52 mmol/L) 中的患者表现出较差的心脏功能和较低的射出分数.
- 多变量分析显示,在所有随访期间,Q4组的全因死亡风险显著增加 (HR:最大随访时1.28,p=0.002).
- 低血和高血都独立地与高血死亡风险增加有关.
结论:
- 血清水平显示出J形的关联与住院心力衰竭患者的全因死亡率.
- 低血和水平≥4.52mmol/L都与短期和长期死亡率的增加有关.
- 建议对血清的狭窄目标范围来优化HF患者的结果.
更多相关视频
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
10:38Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019
相关概念视频
Heart Failure Drugs: Diuretics
Antihypertensive Drugs: Potassium-Sparing Diuretics
Regulation of Sodium and Potassium
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Heart Failure Drugs: Inotropic Agents
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
